Basic Info
  • Grade: pharmaceutical grade

    Factory Location: Guangdong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: Payment before shipping

    Medicinal mechanism: The action mechanism of this product is to interfere with the endoplasmic reticulum in the plasma of the worm, affect the protein metabolism of the worm, and inhibit the swelling of the endoplasmic reticulum and Golgi apparatus, oxidative phosphorylation and ATP. The peak period of action on coccidia is mainly in the first generation of schizozoites (i.e., the third day of the life cycle of coccidia), which prevents the formation of schizozoites, and also has an effect on the second generation of schizozoites, which can inhibit oocyst development. Product use: Anticoccidiosis drug for coccidiosis of poultry and rabbit. It can also treat and prevent aquatic animal sporidiosis. Usage and dosage: Chlorphenguanidine hydrochloride premix: 30 ~ 60g per 1000kg feed; Rabbits 100 ~ 150g. Feeding of chlorphenguanidine hydrochloride powder with bait on aquatic products: one dose, add 20mg per 1kg body weight, halve the seedlings, and continue to use for 3-5 days. (The above contents are measured by chlorphenguanidine hydrochloride) Note: (1) The laying period of laying hens is prohibited. (2) Drug withdrawal period: 5 days for birds, 7 days for rabbits. Packing: 25kg/ bag or bucket Shelf life: 5 years Storage: sealed, dark, dry place.
Send your message to this supplier
  • From:
  • To:
    Guangdong Newkronen Biotech Co., Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Other Products from this supplier

PharmaSources Customer Service